Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Collage AORTIC 2019First iCMLf Forum for African Physicians treating CML
    Overcoming the challengs of treating CML in Africa

    Webstreams of the presentations from the first iCMLf Forum for African Physicians treating CML that took place on November 6th 2019 in Maputo (Mozambique) are now available to view. This first iCMLf Forum in Africa was presented in partnership with The Max Foundation and focused on overcoming the challenges of treating CML in Africa with perspectives from Tanzania, Ghana, Botswana and Nigeria.

    Topics include:

    1. Monitoring CML in a low resource setting
      Dr Oliver Henke (Tanzania)
      Dr Amma Benneh-Akwasi Kuma (Ghana)
    2. Responsible management in the era of five TKIs
      Professor Tim Hughes (Australia) 
      Dr Anthony Oyekunle (Nigeria/Botswana)

    Click on the presentations below to view the webstreams and see the slides.
    (We are very grateful for the support of Brandcast media to produce these web streams) 
     

      

     

     

    Henke AORTIC 2019

    Dr Oliver Henke
    Moshi, Tanzania

    Monitoring CML in a low resource setting - an experience from Tanzania

    Topics include: Recommendations for monitoring of first-line TKI therapy, Monitoring tools:availability and costs, Can we reduce the frequency of PCR monitoring?, Specific data from Tanzania

     

      

     

    Benneh AORTIC 2019

    Dr Amma Benneh-Akwasi Kuma
    Accra, Ghana

    Monitoring CML in a low resource setting - an experience from Ghana

    Topics include: Best practice; how to monitor patients on TKI by ELN; The Karle-Bu Teaching Hospital; experience with monitoring; challenges that affect monitoring in low and middle-income countries.

     

     

     

    Tim Hughes 2019 iCMLf Forum


    Professor Tim Hughes
    Adelaide, Australia

    Responsible management in the era of 5 TKIs

    Topics include: Heterogeneity of response to TKI therapy in CML, overall goals of CML therapy and prerequisites, deep molecular response and treatment free remission in the Adelaide cohort, prioritising molecular testing.

     

      

     

    Oyekunle AORTIC 2019

    Dr Anthony Oyekule
    Ile-Ife, Nigeria / Gaborone, Botswana

    Responsible management in the era of 5 TKIs - an experience from Africa

    Topics include: Imatinib therapy in Nigeria 2003 - 2013; sub-optimal response in Nigeria; Is it ever safe to stop TKI treatment in CML?; TFR studies in CML-CP; ESMO TFR minimum requirements; summary and suggestions.